enow.com Web Search

  1. Ad

    related to: when was dapagliflozin approved

Search results

  1. Results from the WOW.Com Content Network
  2. Dapagliflozin - Wikipedia

    en.wikipedia.org/wiki/Dapagliflozin

    Dapagliflozin was approved for medical use in the United States in January 2014. [66] [36] In 2020, the US FDA expanded the indications for dapagliflozin to include treatment for adults with heart failure with reduced ejection fraction to reduce the risk of cardiovascular death and hospitalization for heart failure. [11]

  3. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    Canagliflozin is the first SGLT2 inhibitor to be approved for use in the United States. It was approved in March 2013, under the brand name Invokana and it was also marketed throughout the European Union under the same name. [26] [27] Dapagliflozin, (brand name Forxiga), was approved by the EU in 2012, the first SGLT2 inhibitor approved ...

  4. Discovery and development of gliflozins - Wikipedia

    en.wikipedia.org/wiki/Discovery_and_development...

    The first discovered c-glucoside was the drug dapagliflozin. [1] [14] [15] Dapagliflozin was the first highly selective SGLT-2-inhibitor approved by the European Medicines Agency. [16] All SGLT-2 inhibitors in clinical development are prodrugs that have to be converted to its active 'A' form for activity. [9]

  5. Forxiga ™ (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in European Union for Treatment of Type 2 Diabetes Forxiga, a once-daily oral agent, provides ...

  6. New Phase III Data Showed Dapagliflozin Significantly ... - AOL

    www.aol.com/2013/09/24/new-phase-iii-data-showed...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Dapagliflozin/metformin - Wikipedia

    en.wikipedia.org/wiki/Dapagliflozin/metformin

    Dapagliflozin/metformin was approved for use in the European Union in January 2014, [3] in the United States in February 2014, [5] [6] and in Australia in July 2014. [7]

  8. LAMA + LABA = Double-Digit Jump - AOL

    www.aol.com/news/2012-07-03-lama-laba-double...

    Theravance's (NAS: THRX) investors are breathing easy. Shares jumped 11% yesterday, and they're up another 8% today. All because a few phase 3 programs read out positive. And by a few, I mean four.

  9. Canagliflozin - Wikipedia

    en.wikipedia.org/wiki/Canagliflozin

    Canagliflozin was approved for medical use in the United States, in the European Union, and in Australia in 2013. [3] [4] ... Canagliflozin, dapagliflozin, and ...

  1. Ad

    related to: when was dapagliflozin approved